Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1

Novo Nordisk will pay Lexicon Pharmaceuticals up to $1 billion to license its experimental obesity treatment.

Investors Business Daily

How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback

ADMA Biologics is Thursday's IBD Stock Of The Day. After an accounting debacle hammered shares in 2024, ADMA stock is making a comeback.

Investors Business Daily

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win

This IBD 50 holding holds top notch ratings amid a market downturn.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

Viking Therapeutics stock skidded Wednesday despite the "encouraging" speed with which the company enrolled patients in an obesity study.

Investors Business Daily

Why are users of 23andMe being urged to delete their data?

Genetic testing company’s bankruptcy proceedings could result in auction of the genetic data of 15 million users.

Al Jazeera

IBD 50's Axsome Therapeutics Dives On Mixed ADHD Results. Why Analysts Aren't Worried.

Axsome stock tumbled Tuesday after Axsome Therapeutics issued mixed results for its drug, Sunosi, in ADHD treatment.

Investors Business Daily

Man who claimed Roundup caused his cancer awarded $2.1billion

The verdict marks the latest in a long-running series of court battles Monsanto has faced over its Roundup herbicide

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion

The Guardian - UK

Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio

Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.

Investors Business Daily

ADMA Stock Builds A Base As Profits Continue To Soar

This biopharmaceutical firm specializes in treatments to prevent and treat infectious diseases.

Investors Business Daily

ARS Pharma Retakes Its 50-Day Line In Bullish Post-Earnings Move. Here's Why.

Shares of ARS Pharmaceuticals bounded higher Thursday after the company reported an unexpected fourth-quarter metrics.

Investors Business Daily

UK pharmacies could cut hours unless NHS provides ‘new and sufficient’ funding

The National Pharmacy Association has recommended collective action for the first time in its history

The Guardian - UK

Incyte Loses 9% As Skin Disease Drug Looks 'Viable, But Not Competitive'

Incyte's skin disease treatment looks "viable, but not competitive with biologics," an analyst said Monday as Incyte stock fell.

Investors Business Daily

AMD manager reports 45% GPU retail market share in Japan — Eyes 70% as the next target

AMD marketing manager Yoshiaki Sato reported that Radeon GPUs have accounted for 45% of GPU sales in Japan, presumably since RDNA 4 launched.

Tom’s Hardware

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’

UK pharma group acquires Belgium’s EsoBiotec as it announces EU has approved Imfinzi lung cancer drug

Investors Business Daily

AstraZeneca Stock Nears Buy Point After Long Run In Declining Market

This biopharmaceutical stock is nearing a buy point of a cup-with-handle base.

The Guardian - UK

Ireland could lose pharma tax to US after Trump accusations, experts warn

Predictions that US firms could retain manufacturing plants in Ireland but move profits back to America

Investors Business Daily

This Medical Services Stock Looks Relatively Healthy In A Sick Market

This medical supplies distributor raised its 2025 earnings outlook on Monday. Cencora stock is near a buy point of a newly formed base.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion

Roche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.

Investors Business Daily

Biotech Stock TG Therapeutics Hits A High In Market Meltdown

Biotech stock TG Therapeutics is outperforming the major indexes in a declining stock market. TGTX stock hit a new high on Friday.

The Independent UK

CVS is opening more standalone pharmacies after shuttering 1,000 stores

CVS will open a dozen new stores, but they’ll be half the size of a typical location

Tom’s Hardware

Raspberry Pi powers briefcase-sized PiEEG 'Bio Lab' project

Blink twice to control the robot arm

Investors Business Daily

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.

Investors Business Daily

Senators Grill FDA Nominee Marty Makary Over Abortion Pills, Vaccines

Senators grilled Dr. Marty Makary on Thursday over his views on access to abortion pills and vaccines. Makary could soon head the FDA.

Evening Standard

Why neurohacking is the new biohacking

Brain training just got an upgrade: neurohacking is the latest wellness microtrend, but is there a way to do it without breaking the bank?

1 2 3 4 5

People

Margaret Kaczor Andrew

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Investor Business Daily

the Food and Drug Administration

158 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.